Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality following heart transplantation (HT). Reduced cardiovascular mortality and morbidity have been reported in non-HT patients treated with metformin. Given the high prevalence of type 2 diabetes mellitus (T2DM)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cardiovasc Diabetol
Главные авторы: Ram, Eilon, Lavee, Jacob, Tenenbaum, Alexander, Klempfner, Robert, Fisman, Enrique Z., Maor, Elad, Ovdat, Tal, Amunts, Sergei, Sternik, Leonid, Peled, Yael
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6747732/
https://ncbi.nlm.nih.gov/pubmed/31526382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0925-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы